Kelly K Hunt

29PUBLICATIONS
184CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMidwifery not elsewhere classifiedMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Sep 22, 2026
Zanidatamab in patients with early stage HER2-positive breast cancer: the NeoZanHER phase 2 single-arm open-label trial.

|Aug 21, 2026
Initiation of Gabapentin with Opioids and Risk of Respiratory Cardiovascular and Opioid-Related Adverse Events Following Surgery for Breast Cancer.

|Feb 26, 2026
The Impact of Vascular Management on Postoperative Complications in Patients Undergoing Surgery for Retroperitoneal Leiomyosarcoma.

Neha Malik, Seokhun Kim, Christopher P Scally

|Jan 28, 2026
Prevalence and Outcomes of HER2-Low Versus HER2-0 Status in Patients with Metastatic Breast Cancer.

Akshara Singareeka Raghavendra, Diane D Liu, Senthil Damodaran

|Jan 22, 2026
CDK2 inhibitor BLU-222 synergizes with CDK4/6 inhibitors in drug resistant breast cancers through p21/p27 induction.

Linjie Luo, Yan Wang, Tuyen Bui

|Dec 24, 2025
Rb1 deficiency induces synthetic lethality with ATR and PKMYT1 coinhibition in breast cancer cell lines and patient-derived xenografts.

Xiao-Ting Jiang, Mei-Kuang Chen, Jiwang Lee

Pageof 5

Frequent Collaborators

8 joint publications

Khandan Keyomarsi

7 joint publications

Debu Tripathy

6 joint publications

Yan Wang

4 joint publications

Mi Li